Related references
Note: Only part of the references are listed.PLA2G7 Genotype, Lipoprotein-Associated Phospholipase A2 Activity, and Coronary Heart Disease Risk in 10 494 Cases and 15 624 Controls of European Ancestry
Juan P. Casas et al.
CIRCULATION (2010)
Lipoprotein-Associated Phospholipase A2 Activity and Incident Coronary Heart Disease Among Men and Women With Type 2 Diabetes
Ida J. Hatoum et al.
DIABETES (2010)
A catalogue of reporting guidelines for health research
I. Simera et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Implication of lipoprotein associated phospholipase A2 activity in oxLDL uptake by macrophages
Konstantinos P. Markakis et al.
JOURNAL OF LIPID RESEARCH (2010)
Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
LANCET (2010)
The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity
Grazyna Wojcicka et al.
LIFE SCIENCES (2010)
The role of lipoprotein-associated phospholipase A(2) in atherosclerosis may depend on its lipoprotein carrier in plasma
Constantinos C. Tellis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus
Robin P. F. Dullaart et al.
CLINICAL ENDOCRINOLOGY (2009)
Lipoprotein-associated phospholipase A(2) and atherosclerosis
Robert L. Wilensky et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study
Sotirios Tsimikas et al.
EUROPEAN HEART JOURNAL (2009)
Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke -: A population-based cohort study from Malmo, Sweden
Margaretha Persson et al.
ATHEROSCLEROSIS (2008)
Association of Lipoprotein-Associated Phospholipase A2 Mass and Activity with Coronary and Aortic Atherosclerosis: Findings from the Dallas Heart Study
Emmanouil S. Brilakis et al.
CLINICAL CHEMISTRY (2008)
Serum platelet-activating factor acetylhydrolase activity: A novel potential inflammatory marker in type 1 diabetes
Marilia de Brito Gomes et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2008)
Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects
Margaretha Persson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
The epidemiology of Lp-PLA2:: Distribution and correlation with cardiovascular risk factors in a population-based cohort
Margaretha Persson et al.
ATHEROSCLEROSIS (2007)
Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitus
P. T. E. Wootton et al.
ATHEROSCLEROSIS (2006)
The role of lipoprotein-associated phospholipase A2 in the metabolic syndrome and diabetes
Hiroshi Noto et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)
Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis - The Rotterdam study
I Kardys et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke
MJ Caslake et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2005)
Lack of association between carotid intima-media thickness and PAF-acetylhydrolase mass and activity in patients with primary hyperlipidemia
DN Kiortsis et al.
ANGIOLOGY (2005)
Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus
T Kujiraoka et al.
JOURNAL OF LIPID RESEARCH (2003)
Association of plasma PAF acetylhydrolase gene polymorphism with IMT of carotid arteries in Japanese type 2 diabetic patients
I Yamamoto et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2003)
Diabesity: An inflammatory metabolic condition
MI Schmidt et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2003)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease.
CJ Packard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
